TickerLeague

Free Cash Flow for Revolution Medicines (RVMD)

Free Cash Flow for Revolution Medicines (RVMD): headline value -$1.07B · YoY +60.9%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

-$1.07B

YoY change

+60.9%

5Y CAGR

N/A

Peak year (2018)

-$286,000

Latest annual

-$913.73M

Free Cash Flow history chart for Revolution Medicines (RVMD) from 2017 to 2025

Free Cash Flow history table for Revolution Medicines (RVMD) from 2017 to 2025

Fiscal yearPeriod endedReportedFree Cash FlowYoYYoY change
2025-$913.73M+60.9%-$345.99M
2024-$567.74M+58.5%-$209.44M
2023-$358.30M+52.3%-$123.08M
2022-$235.22M+53.0%-$81.51M
2021-$153.71M+49.2%-$50.71M
2020-$103.00M+97.3%-$50.79M
2019-$52.20M+18153.5%-$51.92M
2018-$286,000-98.9%+$26.44M
2017-$26.72M

Free Cash Flow values are taken from Revolution Medicines's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, Revolution Medicines (RVMD) reported free cash flow of -$913.73M – surged 60.9% year-over-year.

The dataset's maximum free cash flow sits at -$286,000 (2018); the minimum reading of -$913.73M dates to 2025.

Revolution Medicines (RVMD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $14.22B.

Revolution Medicines Free Cash Flow by Year

Revolution Medicines Free Cash Flow 2025: -$913.73M

Revolution Medicines free cash flow in 2025 was -$913.73M, surged 60.9% from 2024. This figure represents the lowest annual value in the available history.

Revolution Medicines Free Cash Flow 2024: -$567.74M

Revolution Medicines free cash flow in 2024 was -$567.74M, surged 58.5% from 2023.

Revolution Medicines Free Cash Flow 2023: -$358.30M

Revolution Medicines free cash flow in 2023 was -$358.30M, surged 52.3% from 2022.

Revolution Medicines Free Cash Flow 2022: -$235.22M

Revolution Medicines free cash flow in 2022 was -$235.22M, surged 53.0% from 2021.

Revolution Medicines Free Cash Flow 2021: -$153.71M

Revolution Medicines free cash flow in 2021 was -$153.71M.

See more financial history for Revolution Medicines (RVMD).

Sector peers — Free Cash Flow

Companies in the same sector as Revolution Medicines, ranked by their latest free cash flow.

CompanyFree Cash FlowSector
Novo Nordisk (NVO)$28.99BHealthcare
Johnson & Johnson (JNJ)$19.70BHealthcare
AbbVie (ABBV)$17.82BHealthcare
UnitedHealth Group (UNH)$16.07BHealthcare
Merck & Co. (MRK)$12.36BHealthcare
AstraZeneca (AZN)$11.77BHealthcare
Eli Lilly (LLY)$8.97BHealthcare
Amgen (AMGN)$8.10BHealthcare

Frequently asked questions

What is Revolution Medicines's free cash flow?

Latest reported free cash flow for Revolution Medicines (RVMD) is -$1.07B (period ending March 31, 2026).

How has Revolution Medicines free cash flow changed year-over-year?

Revolution Medicines (RVMD) free cash flow changed +60.9% year-over-year on the latest annual filing.

When did Revolution Medicines free cash flow hit its highest annual value?

Revolution Medicines free cash flow reached its highest annual value of -$286,000 in 2018.

What was Revolution Medicines free cash flow in 2024?

Revolution Medicines (RVMD) free cash flow in 2024 was -$567.74M.

What was Revolution Medicines free cash flow in 2025?

Revolution Medicines (RVMD) free cash flow in 2025 was -$913.73M.

RVMD Key Financials

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.